Selected research
Industry Research
Research Grade Plasmid DNA Manufacturing Industry Research Report 2026
Market perspective
The global Research Grade Plasmid DNA Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Research Grade Plasmid DNA Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Research Grade Plasmid DNA Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Research Grade Plasmid DNA Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Research Grade Plasmid DNA Manufacturing include Charles River Laboratories, Creative Biogene, AmplifyBio, Catalent Biologics, PlasmidFactory, GenScript ProBio, Aldevron LLC, PackGene Biotech lnc and WuXi Advanced Therapies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Research Grade Plasmid DNA Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Research Grade Plasmid DNA Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Research Grade Plasmid DNA Manufacturing Market by Company
Charles River Laboratories
Creative Biogene
AmplifyBio
Catalent Biologics
PlasmidFactory
GenScript ProBio
Aldevron LLC
PackGene Biotech lnc
WuXi Advanced Therapies
Polyplus
VectorBuilder
Pharmaron
AGC Biologics
Genovac
Xpress Biologics
VGXI
Cepham Life Sciences
Research Grade Plasmid DNA Manufacturing Segment by Type
Small-scale Manufacturing (<100 mg)
Pilot scale Manufacturing (<1 g)
Large-scale Manufacturing (>1 g)
Research Grade Plasmid DNA Manufacturing Segment by Application
In Vitro
Preclinical Studies
Others
Research Grade Plasmid DNA Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Research Grade Plasmid DNA Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Research Grade Plasmid DNA Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Research Grade Plasmid DNA Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Research Grade Plasmid DNA Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small-scale Manufacturing (<100 mg)
- Pilot scale Manufacturing (<1 g)
- Large-scale Manufacturing (>1 g)
Applications
- In Vitro
- Preclinical Studies
- Others
Companies covered
- Charles River Laboratories
- Creative Biogene
- AmplifyBio
- Catalent Biologics
- PlasmidFactory
- GenScript ProBio
- Aldevron LLC
- PackGene Biotech lnc
- WuXi Advanced Therapies
- Polyplus
- VectorBuilder
- Pharmaron
- AGC Biologics
- Genovac
- Xpress Biologics
- VGXI
- Cepham Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Research Grade Plasmid DNA Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Small-scale Manufacturing (<100 mg)
- 2.2.3 Pilot scale Manufacturing (<1 g)
- 2.2.4 Large-scale Manufacturing (>1 g)
- 2.3 Research Grade Plasmid DNA Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 In Vitro
- 2.3.3 Preclinical Studies
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Research Grade Plasmid DNA Manufacturing Breakdown Data by Type
- 3.1 Global Research Grade Plasmid DNA Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Research Grade Plasmid DNA Manufacturing Forecasted Market Size by Type (2027-2032)
4 Research Grade Plasmid DNA Manufacturing Breakdown Data by Application
- 4.1 Global Research Grade Plasmid DNA Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Research Grade Plasmid DNA Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Research Grade Plasmid DNA Manufacturing Market Perspective (2021-2032)
- 5.2 Global Research Grade Plasmid DNA Manufacturing Growth Trends by Region
- 5.2.1 Global Research Grade Plasmid DNA Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Research Grade Plasmid DNA Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Research Grade Plasmid DNA Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Research Grade Plasmid DNA Manufacturing Market Dynamics
- 5.3.1 Research Grade Plasmid DNA Manufacturing Industry Trends
- 5.3.2 Research Grade Plasmid DNA Manufacturing Market Drivers
- 5.3.3 Research Grade Plasmid DNA Manufacturing Market Challenges
- 5.3.4 Research Grade Plasmid DNA Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Research Grade Plasmid DNA Manufacturing Players by Revenue
- 6.1.1 Global Top Research Grade Plasmid DNA Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Research Grade Plasmid DNA Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Research Grade Plasmid DNA Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Research Grade Plasmid DNA Manufacturing Head Office and Area Served
- 6.4 Global Research Grade Plasmid DNA Manufacturing Players, Product Type & Application
- 6.5 Global Research Grade Plasmid DNA Manufacturing Manufacturers Established Date
- 6.6 Global Research Grade Plasmid DNA Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Research Grade Plasmid DNA Manufacturing Market Size (2021-2032)
- 7.2 North America Research Grade Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Research Grade Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Research Grade Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Research Grade Plasmid DNA Manufacturing Market Size (2021-2032)
- 8.2 Europe Research Grade Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Research Grade Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Research Grade Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Research Grade Plasmid DNA Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Research Grade Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Research Grade Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Research Grade Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Research Grade Plasmid DNA Manufacturing Market Size (2021-2032)
- 10.2 South America Research Grade Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Research Grade Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Research Grade Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Research Grade Plasmid DNA Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Research Grade Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Research Grade Plasmid DNA Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Research Grade Plasmid DNA Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.1.4 Charles River Laboratories Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 Creative Biogene
- 12.2.1 Creative Biogene Company Information
- 12.2.2 Creative Biogene Business Overview
- 12.2.3 Creative Biogene Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.2.4 Creative Biogene Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.2.5 Creative Biogene Recent Developments
- 12.3 AmplifyBio
- 12.3.1 AmplifyBio Company Information
- 12.3.2 AmplifyBio Business Overview
- 12.3.3 AmplifyBio Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.3.4 AmplifyBio Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.3.5 AmplifyBio Recent Developments
- 12.4 Catalent Biologics
- 12.4.1 Catalent Biologics Company Information
- 12.4.2 Catalent Biologics Business Overview
- 12.4.3 Catalent Biologics Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.4.4 Catalent Biologics Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.4.5 Catalent Biologics Recent Developments
- 12.5 PlasmidFactory
- 12.5.1 PlasmidFactory Company Information
- 12.5.2 PlasmidFactory Business Overview
- 12.5.3 PlasmidFactory Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.5.4 PlasmidFactory Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.5.5 PlasmidFactory Recent Developments
- 12.6 GenScript ProBio
- 12.6.1 GenScript ProBio Company Information
- 12.6.2 GenScript ProBio Business Overview
- 12.6.3 GenScript ProBio Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.6.4 GenScript ProBio Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.6.5 GenScript ProBio Recent Developments
- 12.7 Aldevron LLC
- 12.7.1 Aldevron LLC Company Information
- 12.7.2 Aldevron LLC Business Overview
- 12.7.3 Aldevron LLC Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.7.4 Aldevron LLC Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.7.5 Aldevron LLC Recent Developments
- 12.8 PackGene Biotech lnc
- 12.8.1 PackGene Biotech lnc Company Information
- 12.8.2 PackGene Biotech lnc Business Overview
- 12.8.3 PackGene Biotech lnc Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.8.4 PackGene Biotech lnc Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.8.5 PackGene Biotech lnc Recent Developments
- 12.9 WuXi Advanced Therapies
- 12.9.1 WuXi Advanced Therapies Company Information
- 12.9.2 WuXi Advanced Therapies Business Overview
- 12.9.3 WuXi Advanced Therapies Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.9.4 WuXi Advanced Therapies Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.9.5 WuXi Advanced Therapies Recent Developments
- 12.10 Polyplus
- 12.10.1 Polyplus Company Information
- 12.10.2 Polyplus Business Overview
- 12.10.3 Polyplus Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.10.4 Polyplus Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.10.5 Polyplus Recent Developments
- 12.11 VectorBuilder
- 12.11.1 VectorBuilder Company Information
- 12.11.2 VectorBuilder Business Overview
- 12.11.3 VectorBuilder Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.11.4 VectorBuilder Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.11.5 VectorBuilder Recent Developments
- 12.12 Pharmaron
- 12.12.1 Pharmaron Company Information
- 12.12.2 Pharmaron Business Overview
- 12.12.3 Pharmaron Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.12.4 Pharmaron Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.12.5 Pharmaron Recent Developments
- 12.13 AGC Biologics
- 12.13.1 AGC Biologics Company Information
- 12.13.2 AGC Biologics Business Overview
- 12.13.3 AGC Biologics Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.13.4 AGC Biologics Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.13.5 AGC Biologics Recent Developments
- 12.14 Genovac
- 12.14.1 Genovac Company Information
- 12.14.2 Genovac Business Overview
- 12.14.3 Genovac Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.14.4 Genovac Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.14.5 Genovac Recent Developments
- 12.15 Xpress Biologics
- 12.15.1 Xpress Biologics Company Information
- 12.15.2 Xpress Biologics Business Overview
- 12.15.3 Xpress Biologics Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.15.4 Xpress Biologics Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.15.5 Xpress Biologics Recent Developments
- 12.16 VGXI
- 12.16.1 VGXI Company Information
- 12.16.2 VGXI Business Overview
- 12.16.3 VGXI Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.16.4 VGXI Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.16.5 VGXI Recent Developments
- 12.17 Cepham Life Sciences
- 12.17.1 Cepham Life Sciences Company Information
- 12.17.2 Cepham Life Sciences Business Overview
- 12.17.3 Cepham Life Sciences Revenue in Research Grade Plasmid DNA Manufacturing Business (2021-2026)
- 12.17.4 Cepham Life Sciences Research Grade Plasmid DNA Manufacturing Product Portfolio
- 12.17.5 Cepham Life Sciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst